Works matching DE "PEMBROLIZUMAB"

Results: 1209
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Tolerability and efficacy of the cancer vaccine UV1 in patients with recurrent or metastatic PD-L1 positive head and neck squamous cell carcinoma planned for first-line treatment with pembrolizumab - the randomized phase 2 FOCUS trial.

    Published in:
    Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1283266
    By:
    • Brandt, Anna;
    • Schultheiss, Christoph;
    • Klinghammer, Konrad;
    • Schafhausen, Philippe;
    • Chia-Jung Busch;
    • Blaurock, Markus;
    • Hinke, Axel;
    • Tometten, Mareike;
    • Dietz, Andreas;
    • Müller-Richter, Urs;
    • Hahn, Dennis;
    • Alt, Jürgen;
    • Stein, Alexander;
    • Binder, Mascha
    Publication type:
    Article
    17
    18

    Pembrolizumab and trastuzumab in combination with FLOT in the perioperative treatment of HER2-positive, localized esophagogastric adenocarcinoma--a phase II trial of the AIO study group (AIO STO 0321).

    Published in:
    Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1272175
    By:
    • Tintelnot, Joseph;
    • Stein, Alexander;
    • Al-Batran, Salah-Eddin;
    • Ettrich, Thomas;
    • Götze, Thorsten;
    • Grün, Barbara;
    • Haag, Georg Martin;
    • Heuer, Vera;
    • Hofheinz, Ralf-Dieter;
    • Homann, Nils;
    • Bröring, Tobias Sebastian;
    • Cruz, Mariana Santos;
    • Kurreck, Annika;
    • Lorenzen, Sylvie;
    • Moosmann, Nicolas;
    • Müller, Christian;
    • Schuler, Markus;
    • Siegler, Gabriele;
    • Binder, Mascha;
    • Gökkurt, Eray
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29

    Postoperative adjuvant radiochemotherapy with cisplatin versus adjuvant radiochemotherapy with cisplatin and pembrolizumab in locally advanced head and neck squamous cell carcinoma- the study protocol of the Adrisk trial.

    Published in:
    Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1128176
    By:
    • Wiegand, Susanne;
    • Wichmann, Gunnar;
    • Vogt, Jeannette;
    • Vogel, Kathrin;
    • Franke, Annegret;
    • Kuhnt, Thomas;
    • Lordick, Florian;
    • Scheuble, Anne-Marie;
    • Hambsch, Peter;
    • Brossart, Peter;
    • Bauernfeind, Franz Georg;
    • Kaftan, Holger;
    • Maschmeyer, Georg;
    • Paland, Matthias;
    • Münter, Marc;
    • Lewitzki, Victor;
    • Rotter, Nicole;
    • Stromberger, Carmen;
    • Beck, Marcus;
    • Dommerich, Steffen
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40

    Inhibiting Histone and DNA Methylation Improves Cancer Vaccination in an Experimental Model of Melanoma.

    Published in:
    Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.799636
    By:
    • De Beck, Lien;
    • Awad, Robin Maximilian;
    • Basso, Veronica;
    • Casares, Noelia;
    • De Ridder, Kirsten;
    • De Vlaeminck, Yannick;
    • Gnata, Alessandra;
    • Goyvaerts, Cleo;
    • Lecocq, Quentin;
    • San José-Enériz, Edurne;
    • Verhulst, Stefaan;
    • Maes, Ken;
    • Vanderkerken, Karin;
    • Agirre, Xabier;
    • Prosper, Felipe;
    • Lasarte, Juan José;
    • Mondino, Anna;
    • Breckpot, Karine
    Publication type:
    Article
    41
    42
    43

    Targeting PD-I/PD-LI in lung cancer: current perspectives.

    Published in:
    Lung Cancer: Targets & Therapy, 2015, v. 6, p. 55, doi. 10.2147/LCTT.S55176
    By:
    • González-Cao, María;
    • Karachaliou, Niki;
    • Viteri, Santiago;
    • Morales-Espinosa, Daniela;
    • Teixidó, Cristina;
    • Ruiz, Jesús Sánchez;
    • Molina-Vila, Miquel Ángel;
    • Santarpia, Mariacarmela;
    • Rosell, Rafael
    Publication type:
    Article
    44
    45
    46
    47
    48
    49
    50